Close
4

Promoted Content Promoted Content

X

Company profile for Adare Pharma Solutions

Client EmailClient Virtual Booth
ADARE PHARMA SOLUTIONS
  • Connect with Us...

  • Corporate Presentation

  • PharmaSynergy February 2021

  • Executive Interview On Growth & Strategy

  • THL Partners & Frazier acquires Adare Pharmaceuticals

  • Products for Licensing 2020

  • Adare Aquires Orbis Biosciences

  • All Services

  • Analytical

  • Drug Product Manufacturing

  • API & Drug Product Development

  • Diffucaps® Customized Release Technology

  • Microcaps® Taste Masking Technology

  • AdvaTab® Orally Disintegrating Tablets

  • MMTS™ Multi Mini Tablet System

  • DIFFUTAB® Technology

  • Optimum® Technology

  • Stratum™ Technology

  • ORBEXA™

  • Coating Technology

  • Bioavailability Enhancement Technology

  • Chewable Tablet Formulation Development

  • Unisun® Technology

  • Orodispersible Tablet (ODT) Development

  • Pediatric Formulation Development

  • Solubility Enhancement

PharmaCompass

Virtual Booth Transforming oral delivery challenges into proprietary product solutions.

Adare Pharma Solutions is a global technology-driven specialty CDMO providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health & OTC markets. Adare’s technology platforms specialize in ODT, taste masking & customized drug release. With over 30 years of proven legacy, we have successfully developed & manufactured more than 40 products sold by customers in more than 100 countries globally. We have 4 sites located in the US & EU with over 600 employees worldwide. Our sites are compliant with cGMP criteria & approved to handle controlled substances.
Adare-Pharma-Solutions
Adare Pharma Solutions
United_States_of_America Flag
Country
Country
UNITED STATES
Address
Address
Princeton Pike Corporate Center 1200 Lenox Drive, Suite 100 Lawrenceville, NJ 08648
Telephone
Telephone
+1-609-450-1312
Twitter
Twitter
Contact Info
Others

Email ID:
busdev@adareps.com

left grey arrow
right gray arrow
  • Corporate Presentation
  • PharmaSynergy February 2021
  • Executive Interview On Growth & Strategy
  • THL Partners & Frazier acquires Adare Pharmaceuticals
  • Products for Licensing 2020
  • Adare Aquires Orbis Biosciences

https://www.pharmacompass.com/pdf/party/content/adare-pharma-solutions-party-content-1622612964.pdf

https://www.pharmacompass.com/pdf/party/content/adare-pharma-solutions-party-content-1622612268.pdf

https://www.pharmacompass.com/pdf/party/content/adare-pharma-solutions-party-content-1621576211.pdf

https://www.pharmacompass.com/pdf/party/content/adare-pharmaceuticals-party-content-1600922285.pdf

https://www.pharmacompass.com/pdf/party/content/adare-pharmaceuticals-party-content-1591785887.pdf

https://www.pharmacompass.com/pdf/party/content/adare-pharmaceuticals-party-content-1590558226.pdf

left grey arrow